共 50 条
- [1] Eculizumab in Atypical Hemolytic-Uremic Syndrome [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1377 - 1378
- [2] Eculizumab in Atypical Hemolytic-Uremic Syndrome Reply [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1379 - 1380
- [3] Eculizumab for Atypical Hemolytic-Uremic Syndrome. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05): : 542 - 544
- [4] Gemcitabine-Associated Atypical Hemolytic-Uremic Syndrome Treated with Eculizumab [J]. CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2020, 73 (01): : 77 - 78
- [5] Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (05): : 544 - 546
- [6] More on Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20): : 2142 - 2143
- [7] Prophylactic Eculizumab after Renal Transplantationin Atypical Hemolytic-Uremic Syndrome. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (18): : 1746 - 1748
- [9] More on Eculizumab for Congenital Atypical Hemolytic-Uremic Syndrome Reply [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20): : 2143 - 2143
- [10] Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (23): : 2169 - 2181